Ingrid Bartrop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ingrid Bartrop has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Alvira Hurst
Infant, Child and Adolescent Mental Health Service, Mental Health Department South‐Western Sydney Local Health District Sydney NSW Health Australia
1 shared publicationAnne‐Marie Schlesinger
Discipline of Psychiatry and Mental Health, School of Clinical Medicine University of New South Wales Sydney Australia
1 shared publication- Avick Rahman
Department of Psychological Sciences Swinburne University of Technology Melbourne Australia
1 shared publication - Craig Andrews
Infant, Child and Adolescent Mental Health Service, Mental Health Department South‐Western Sydney Local Health District Sydney NSW Health Australia
1 shared publication Giles Barton
Infant, Child and Adolescent Mental Health Service, Mental Health Department South‐Western Sydney Local Health District Sydney NSW Health Australia
1 shared publication- Hasan Jamali
Discipline of Psychiatry and Mental Health, School of Clinical Medicine University of New South Wales Sydney Australia
1 shared publication
Latest Publications
- Open Access
- 6 August 2026
- Published by Wiley in Journal of Child and Adolescent Psychiatric Nursing
- Vol. 39 (3) , e70071
A Cross‐Sectional Study of Prescribed Sleep Medication Use and Its Clinical and Demographic Factors Among Young People Receiving Mental Health Crisis Interventions in Sydney, Australia
Background: Clinical and demographic factors influencing prescribed sleep medication use in children and young people (CYP) have been studied inadequately. We aimed to examine the prevalence of prescribed sleep medication use among CYP experiencing mental health crises and its associations with clinical and demographic factors. Materials and Methods: Electronic medical records of CYP ( n = 201) attending the Macarthur Safeguards Acute Mental Health Crisis Service (referred to as the Safeguards Service) in Sydney, Australia, were reviewed. Descriptive statistics and bivariate and multivariate logistic regression analyses were performed. Multivariate logistic regression was used to estimate the Adjusted Odds Ratio (AOR) with 95% confidence intervals, examining the associations between prescribed sleep medication use and clinical and demographic factors. Results: The prevalence of prescribed sleep medication use (e.g., melatonin, benzodiazepines) among CYP was 20.9%. Multivariate regression analysis indicated that CYP's length of stay with the Safeguards Service was positively associated with increased prescribed sleep medication use (AOR = 3.61, 95% CI: 1.19–10.94, p = 0.023). CYP who were diagnosed with trauma‐related psychiatric conditions tended to use more prescribed sleep medication use (AOR = 2.81, 95% CI: 1.09–7.19, p < 0.032). Moreover, multiple medication prescriptions (polypharmacy) were strongly associated with increased prescription of SM (AOR = 11.36, 95% CI: 4.46–28.95, p < 0.000). Conclusion: Prescribed sleep medication use is significant in CYP experiencing mental health crises. This requires careful consideration due to potential risks, drug interactions, and limited evidence of long‐term benefits. There needs to be a focus on addressing the underlying causes of sleep difficulties and exploring adjunct non‐pharmacological interventions, especially for those with trauma‐related psychiatric conditions, those who tend to have a longer length of stay and are prescribed multiple medications, including for sleep.
- 6 August 2026
- Published by Wiley in Journal of Child and Adolescent Psychiatric Nursing
- Vol. 39 (3) , e70071
Open AccessA Cross‐Sectional Study of Prescribed Sleep Medication Use and Its Clinical and Demographic Factors Among Young People Receiving Mental Health Crisis Interventions in Sydney, Australia
Background: Clinical and demographic factors influencing prescribed sleep medication use in children and young people (CYP) have been studied inadequately. We aimed to examine the prevalence of prescribed sleep medication use among CYP experiencing mental health crises and its associations with clinical and demographic factors. Materials and Methods: Electronic medical records of CYP ( n = 201) attending the Macarthur Safeguards Acute Mental Health Crisis Service (referred to as the Safeguards Service) in Sydney, Australia, were reviewed. Descriptive statistics and bivariate and multivariate logistic regression analyses were performed. Multivariate logistic regression was used to estimate the Adjusted Odds Ratio (AOR) with 95% confidence intervals, examining the associations between prescribed sleep medication use and clinical and demographic factors. Results: The prevalence of prescribed sleep medication use (e.g., melatonin, benzodiazepines) among CYP was 20.9%. Multivariate regression analysis indicated that CYP's length of stay with the Safeguards Service was positively associated with increased prescribed sleep medication use (AOR = 3.61, 95% CI: 1.19–10.94, p = 0.023). CYP who were diagnosed with trauma‐related psychiatric conditions tended to use more prescribed sleep medication use (AOR = 2.81, 95% CI: 1.09–7.19, p < 0.032). Moreover, multiple medication prescriptions (polypharmacy) were strongly associated with increased prescription of SM (AOR = 11.36, 95% CI: 4.46–28.95, p < 0.000). Conclusion: Prescribed sleep medication use is significant in CYP experiencing mental health crises. This requires careful consideration due to potential risks, drug interactions, and limited evidence of long‐term benefits. There needs to be a focus on addressing the underlying causes of sleep difficulties and exploring adjunct non‐pharmacological interventions, especially for those with trauma‐related psychiatric conditions, those who tend to have a longer length of stay and are prescribed multiple medications, including for sleep.